Bem vindo  

ACONTECE NA ABIFINA

ABIFINA divulga notícias e artigos sobre a luta contra o coronavírus (08/04/2020)

A ABIFINA criou uma área exclusiva no site para notícias e artigos relacionados às ações de governos, empresas e instituições de pesquisa do Brasil e do mundo para combater o coronavírus. 

Daremos destaque aos estudos sobre vacinas, drogas em desenvolvimento, drogas tradicionais, protocolos clínicos e suprimentos de IFAs. Acompanhe as atualizações!

 

Situação patentária de vacinas relacionadas à Covid-19

08.04.2020 - Dando prosseguimento ao estudo sobre possíveis moléculas para tratamento e prevenção da COVID-19, a partir das informações obtidas no estudo publicado pela American Chemical Society , a ABIFINA traz um levantamento das patentes correspondentes brasileiras de vacinas que possam ser utilizadas na pandemia de COVID-19

 

Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production

April 07, 2020 - Besides social isolation, identification of the suitable clinically approved drugs to be repurposed could lead to short-term action to reduce mortality

 

Open for outbreaks

April 07, 2020 - In the onslaught of the COVID-19 pandemic, the open sharing of materials, information and data is gaining increasing importance in biotech.

 

Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries

April 03, 2020 - A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings

 

EMA provides recommendations on compassionate use of remdesivir for COVID-19

April 03, 2020 - During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union

 

International regulators discuss available knowledge supporting COVID-19 medicine development

April 03, 2020 - On 2 April, regulators from around the world joined the second workshop on COVID-19 organised by the European Medicines Agency (EMA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA)

 

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID‐19: initial assessment

April 02, 2020 - Several antiretroviral drugs are being considered the treatment of COVID‐19, the disease caused by a newly identified coronavirus, (SARS‐CoV‐2).

 

HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients

April 02, 2020 - FDA issues emergency use authorization for donated hydroxychloroquine sulfate, chloroquine phosphate

 

Coronavirus disease (COVID-2019) R&D

April 02, 2020 - On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China

 

Optimizing the Trade-off Between Learning and Doing in a Pandemic

April 02, 2020 - The world is united regarding the goal of ending the coronavirus disease 2019 (COVID-19) pandemic but not the strategy to achieve that goal

 

NOTA INFORMATIVA Nº 5/2020-DAF/SCTIE/MS

27.03.2020 - Uso da Cloroquina como terapia adjuvante no tratamento de formas graves do COVID-19

 

Use of antiviral drugs to reduce COVID-19 transmission 

March 27, 2020 - As the coronavirus disease 2019 (COVID-19) spreads, efforts are being made to reduce transmission via standard public health interventions based on isolation of cases and tracing of contacts.

 

EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic

March 27, 2020 - EMA is aware of recent media reports and publications which question whether some medicines, for instance angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs, or sartan medicines), could worsen coronavirus disease (COVID-19)

 

Exportação de cloroquina e azitromicina: veja a RDC 352

March 27, 2020 - De acordo com a Resolução da Diretoria Colegiada 352, a exportação necessitará temporariamente de autorização prévia da Anvisa.

 

Situação patentária de moléculas e composições relacionadas à Covid-19

25.03.2020 - Diante da pandemia da COVID-19, e a partir das informações obtidas por um estudo publicado pela American Chemical Society , a ABIFINA fez um levantamento preliminar das patentes brasileiras correspondentes para as moléculas que estão sendo estudadas para prevenção e/ou tratamento da COVID-19. 

 

Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug

March 26, 2020 - In a surprising turnabout, drugmaker Gilead Sciences asked the Food and Drug administration on Wednesday to rescind orphan status for remdesivir, the company's experimental coronavirus treatment

 

India bans exports of drug touted by Trump as potential Covid-19 treatment

March 26, 2020 - Amendment in Export Policy of Hydroxychloroquine

 

Global regulatory workshop on COVID-19 vaccine development

March 25, 2020 - A virtual meeting, held under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), convening experts from medicines regulatory authorities, the World Health Organisation (WHO) and the European Commission 

 

Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)

March 25, 2020 - In vitro studies revealed that lopinavir/ritonavir and hydroxychloroquine have antiviral activity against Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

 

The Official Chinese Government Guide to Diagnosing and Treating the Novel Coronavirus

March 25, 2020 - You may not have heard of it. It’s now on version 7. You should read it.

 

Resources and Use of Approved Therapies for Treatment of n-CoViD-19 Disease

March 2020 - Therapies Approved by US FDA for Other Conditions

 

The first study of a potential coronavirus vaccine will soon start recruiting healthy volunteers in Georgia at Emory University

Mar 23, 2020 - A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. 

 

Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia

March 23, 2020 - Genentech will also provide 10,000 vials of Actemra to the U.S. Strategic National Stockpile. Current U.S. supply of Actemra for approved indications is not expected to be impacted 

 

WHO launches global megatrial of the four most promising coronavirus treatments

Mar. 22, 2020 - Could any of these drugs hold the key to saving coronavirus disease 2019 (COVID-19) patients from serious harm or death? On Friday, the World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease. 

 

The pandemic pipeline

20 March 2020 - Companies are doing their best to accelerate experimental drugs and vaccines for COVID-19 through the pipeline. Each faces its own set of challenges, but all agree on the need for a radical rethink of the clinical development process for pandemics. 

 

The pandemic pipeline

20 March 2020 - Companies are doing their best to accelerate experimental drugs and vaccines for COVID-19 through the pipeline. Each faces its own set of challenges, but all agree on the need for a radical rethink of the clinical development process for pandemics. 

 

Chloroquine, Past and Present

20 March, 2020 - Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. All content is Derek’s own, and he does not in any way speak for his employer.

 

Sanofi, Regeneron test arthritis drug against COVID-19

March 18, 2020 - New study explores whether dampening IL-6 could address serious coronavirus infections 

 

Chilean Chamber of Deputies approves resolution for compulsory licenses for patents relating to the coronavirus virus

March 17, 2020 - Today, with an overwhelming 127 votes in favor and 0 votes against, the Chilean Chamber of Deputies approved a strong resolution asking the Chilean Government to declare that there is justification for compulsory licenses for vaccines, drugs, diagnostics, devices, supplies, and other technologies useful for the surveillance, prevention, detection, diagnosis and treatment of people infected by the coronavirus virus in Chile.

 

Hydroxychloroquine would be effective, according to Professor Raoult of the IHU in Marseille, after a first limited test

March 17, 2020 - Professor Didier Raoult, director of the IHU in Marseille, presented the first results of the hydroxychloroquine clinical test carried out on 24 patients suffering from coronavirus.

 

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus

16 March 2020 - Estimation of the prevalence and contagiousness of undocumented novel coronavirus (SARS-CoV2) infections is critical for understanding the overall prevalence and pandemic potential of this disease.

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

March 12, 2020 - Since the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, this disease has spread rapidly around the globe. Considering the potential threat of a pandemic, scientists and physicians have been racing to understand this new virus and the pathophysiology of this disease to uncover possible treatment regimens and discover effective therapeutic agents and vaccines.